Company intelligence / Profile preview

EnzymeWorks

China

Ownership: Private
Development stage: Other

Overview

EnzymeWorks develops and supplies enzymes and cofactors for chemical and pharmaceutical manufacturing, as well as contract research, process development, and large-scale manufacturing. The company is industry-recognized for innovation in enzyme-based green chemistry and biocatalysis, filing over 150 patents and contributing to numerous books in the field. The company does not list therapeutic clinical trials but supports pharmaceutical manufacturing and bioprocess innovation.

Modalities: ProteinSmall moleculeBiologic
Industry: Chemicals & Materials

Beyond the preview

Go deeper on EnzymeWorks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnzymeWorks.

Explore the full profile